Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to $1.7 million.

  • Myriad Genetics' Other Non-Current Liabilities fell 9504.37% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 9504.37%. This contributed to the annual value of $2.2 million for FY2024, which is 9467.31% down from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Other Non-Current Liabilities is $1.7 million, which was down 9504.37% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Other Non-Current Liabilities registered a high of $43.9 million during Q4 2022, and its lowest value of $1.7 million during Q3 2025.
  • Over the past 5 years, Myriad Genetics' median Other Non-Current Liabilities value was $30.8 million (recorded in 2021), while the average stood at $25.0 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first surged by 25304.35% in 2024, then plummeted by 9507.39% in 2025.
  • Myriad Genetics' Other Non-Current Liabilities (Quarter) stood at $32.1 million in 2021, then skyrocketed by 36.76% to $43.9 million in 2022, then decreased by 5.92% to $41.3 million in 2023, then crashed by 94.67% to $2.2 million in 2024, then decreased by 22.73% to $1.7 million in 2025.
  • Its Other Non-Current Liabilities was $1.7 million in Q3 2025, compared to $1.9 million in Q2 2025 and $2.0 million in Q1 2025.